Biotech Startups
10,024 companies tagged Biotech, with their investors and founders.
New Vital Signs is developing a wearable monitoring platform that measures a new generation of precision vital signs to detect physiologic changes earlier than traditional monitors, aimed at identifying at-risk patients (e.g. sepsis, trauma, heart failure, traumatic brain injury). Its products include DRIVE (respiratory/circulating volume), TOBI (cerebral autoregulation), and VATMOS (peripheral vascular tone), developed in partnership with the University of Michigan Center for Integrative Research in Critical Care.</parameter> <parameter name="founders">[]
0 investors
0 investors
0 investors
NexGel manufactures FDA-registered and ISO-certified hydrogel patch technology for over-the-counter medications, wound care, cosmetics, and commercial applications. The platform supports integration of active ingredients and is marketed for its versatility and consumer experience.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
NextEvo develops water-soluble CBD products using patented SmartSorb™ technology, validated through peer-reviewed clinical trials. The company applies pharmaceutical-grade science and standards to CBD formulations for consumer health markets.
0 investors
0 investors
0 investors
Nielsen BioSciences develops biopharmaceutical products that assess or treat immune responses, including skin test antigens for Valley Fever and candida infections, and investigational therapeutics for HPV-related lesions.
0 investors
0 investors
0 investors
0 investors
Nirrin builds optical instruments and analytics software for bioprocess teams to generate measurement data across development and manufacturing workflows. Its systems are designed for deployment in regulated biopharma production and quality environments.
0 investors
0 investors
0 investors
0 investors
NJ Bio, Inc. is a contract research and contract development and manufacturing organization (CRO/CDMO) providing integrated chemistry and biology services—including antibody-drug conjugates, bioconjugation, protein and antibody production, cell-based assays, nucleotide/oligonucleotide and mRNA synthesis, and bioanalytical work—to biotech and pharmaceutical companies. It is headquartered in Princeton, New Jersey, with additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India.
0 investors
NK-One Therapeutics is a biotechnology company developing a first-in-class intrathecal molecular therapy (SP-SAP) that selectively disables NK-1 receptor pain-signaling neurons in the spine to treat refractory pain in end-stage cancer patients. The therapy is in a Phase 1 clinical trial and is also intended for veterinary use.
0 investors
NKore BioTherapeutics is a cellular-based biotherapeutics company developing an allogeneic immunotherapy platform based on a proprietary method of activating natural killer (NK) cells, called Supercharged NK (sNK) cells. Its lead therapy, NK101, targets solid and blood cancers in adult and pediatric patients, with human clinical trials planned in the United States beginning in 2027.
0 investors
0 investors